SALT LAKE CITY—Biomerics, a vertically integrated medical device contract manufacturer in the interventional device market, reported that it completed a 100,000-square-foot expansion of its operations in Brooklyn Park, Minnesota. The expansion, driven by increased demand, brings the facility to a total size of 170,000 square feet, the company said in a release.
The investment is intended to benefit customers by consolidating multiple facilities under one roof and expanding Biomerics’ engineering Centers of Excellence for Complex Extrusions, Laser Processing, and Advanced Catheters & Steerables, as well as final assembly operations, according to the release.
Biomerics’s main facility in Brooklyn Park specializes in designing, developing, and manufacturing complex, highly specialized catheters, steerable devices, and delivery systems for the interventional device market.
The 100,000-square-foot expansion includes 20,000 square feet dedicated to expanding micro metals laser processing. It also includes 24,000 square feet for complex extrusion processing, with 2,000 square feet of that certified as ISO class 8 cleanroom space; and 10,000 square feet for advanced catheter processing. The expansion also provides additional areas for employee training and office space, the company said.
According to Biomerics, the new space will allow it to triple extrusion output over the next five years to keep up with increased customer demand for high-quality medical extrusions and catheters. The collaboration of Brooklyn Park’s extrusion and catheter teams with Biomerics’s custom proprietary polyurethane manufacturing team in Salt Lake City is said to combine engineering expertise in proprietary thermoplastic materials and compounds for medical tubing.
This vertical integration marks the launch of Biomerics Advanced Materials & Tubing, the company’s newest Center of Excellence, the company said.
“This expansion consolidates all Biomerics’ Minnesota operations under one roof,” said Tom Winegar, president of Biomerics Brooklyn Park, in the release. “This allows for a one-stop shop for our customers to meet their design and manufacturing needs for micro metals processing, advanced extrusion, product development, advanced catheters and advanced steerables. We are excited to continue to invest in Minnesota and enhance our capabilities for our customers.”
Biomerics provides engineering design and development services, technology transfer manufacturing services, and contract manufacturing services—including sterilization and packaging—for medical device components, subassemblies, and finished medical devices.
The company operates under a certified ISO 13485:2016 quality system. It is also FDA registered and compliant with FDA 21 CFR Part 820, the company said.